Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 9, 2025
Synaptics Announces Fiscal Fourth Quarter 2025 Investor Conference Participation
GlobeNewswire
·
May 9, 2025
SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today announced its participation in the following investor conferences in the fiscal fourth quarter of 2025: Ken Rizvi, Interim CEO and Chief Financial Officer, will …
Sunrise Pact Investment Alliance Announces Intelligent Market Engine Backed by Alaric Wainwright’s NeuroGrid AI Framework
GlobeNewswire
·
May 9, 2025
Seattle, Washington , May 09, 2025 (GLOBE NEWSWIRE) -- Sunrise Pact Investment Alliance has unveiled a new intelligent market engine designed to enhance the precision, speed, and efficiency of investment operations across global markets. Built with …
SEALSQ to Lead the World’s First Space-Based Quantum Key Distribution Proof-of-Concept with the June 2025 Launch of WISeSat 2.1 Embedding WISeKey Quantum RootKey
GlobeNewswire
·
May 9, 2025
Geneva, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, together with …
Celularity Announces Full Year 2024 Operating and Financial Results
GlobeNewswire
·
May 9, 2025
FLORHAM PARK, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced operating and financial results for the year ended December 31, 2024. “We …
Telos Corporation Announces First Quarter 2025 Earnings
GlobeNewswire
·
May 9, 2025
ASHBURN, Va., May 09, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, has posted its 2025 first quarter financial results …
Aqua Security Named Winner in the 2025 Cloud Security Awards
GlobeNewswire
·
May 9, 2025
BOSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Aqua Security, the pioneer in cloud native security, announced today that it has been named the Best Vulnerability/Scanner Assessment Solution in the 2025 Cloud Security Awards. Last year was a record-breaking year, …
Critical Metals Corp Publishes Compelling Deep Diamond Drill Results from Tanbreez Greenland
GlobeNewswire
·
May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, is pleased to publish for the first time, historical deep diamond drill holes DDH 306-13 …
Source Energy Services Announces Normal Course Issuer Bid
GlobeNewswire
·
May 9, 2025
CALGARY, Alberta, May 09, 2025 (GLOBE NEWSWIRE) -- TSX: SHLE Source Energy Services Ltd. (“Source” or the “Company”) is pleased to announce that the Toronto Stock Exchange (the “TSX”) has accepted Source’s notice of intention to implement a Normal Course …
Ocugen Provides Business Update with First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026 Anticipate initiating OCU410ST Phase 2/3 pivotal confirmatory clinical …
Garuda Therapeutics Announces Name Change to Stratus Therapeutics to Reflect Mission of Pioneering Full Hematopoietic System Renewal
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Garuda Therapeutics (“Garuda”), a biotechnology company developing off-the-shelf hematopoietic stem cell (HSC) therapies, today announced that it has changed its name to Stratus Therapeutics, Inc. (“ …
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025
GlobeNewswire
·
May 9, 2025
DURHAM, N.C., May 09, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the …
NextNav Inc. Reports First Quarter 2025 Results and Operational Highlights
GlobeNewswire
·
May 9, 2025
FCC releases Notice of Inquiry (NOI) with bipartisan 4-0 vote NextNav Announces Appointment of Rear Admirals H. Wyman Howard and Lorin Selby to its Board of Directors RESTON, Va., May 09, 2025 (GLOBE NEWSWIRE) -- NextNav Inc. (NASDAQ: NN) a leader in next …
Spectral Medical Announces First Quarter and Provides Corporate Update
GlobeNewswire
·
May 9, 2025
Tigris Trial Enrollment completed Topline results expected to be released in August 2025 Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Spectral Medical …
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine
GlobeNewswire
·
May 9, 2025
Results support potential benefit of efruxifermin (EFX) to elicit fibrosis improvement in patients with compensated cirrhosis (F4 fibrosis) due to MASH 96-week data from SYMMETRY trial presented at EASL Congress 2025 SOUTH SAN FRANCISCO, Calif., May 09, …
uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
GlobeNewswire
·
May 9, 2025
~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no treatment-related serious adverse events ~ ~ Held Type B FDA meetings in …
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
GlobeNewswire
·
May 9, 2025
ALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS …
Kymera Therapeutics Expands Industry Leading Immunology Pipeline with New First-in-Class, Oral IRF5 Degrader Program with Potential to Address Multiple Immuno-Inflammatory Diseases
GlobeNewswire
·
May 9, 2025
IRF5 program strengthens Kymera’s oral immunology pipeline with a complementary mechanism to expand into rheumatic and other autoimmune diseases with a potential best-in-class oral drug IRF5, a historically undrugged transcription factor and master …
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the …
Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 9, 2025
Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) with data expected in 4Q25 KT-579 (IRF5) new …
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 9, 2025
Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025 Novel Kinesin program on track for mid-2025 development candidate nomination and IND filing …